| 4 | Advancing cell-free DNA as a biomarker of damage to heart caused by ionizing radiation. (Wallisch E, Tomita-Mitchell A, Liang HL, Szabo A, Lenarczyk M, Kwitek A, Smith JR, Tutaj M, Baker JE) J Radiat Res 2025 May 23;66(3):329-340 |
| 1 | Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry. (Khush K, Hall S, Kao A, Raval N, Dhingra R, Shah P, Bellumkonda L, Ravichandran A, Van Bakel A, Uriel N, Patel S, Pinney S, DePasquale E, Baran DA, Pinney K, Oreschak K, Kobulnik J, Shen L, Teuteberg J) J Heart Lung Transplant 2024 Sep;43(9):1409-1421 16 Citations |
| 1 | Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant. (Bromberg JS, Bunnapradist S, Samaniego-Picota M, Anand S, Stites E, Gauthier P, Demko Z, Prewett A, Armer-Cabral M, Marshall K, Kaur N, Bloom MS, Tabriziani H, Bhorade S, Cooper M, ProActive Investigators) Transplantation 2024 Sep 01;108(9):1994-2004 24 Citations |
| 1 | Evaluating threshold for donor fraction cell-free DNA using clinically available assay for rejection in pediatric and adult heart transplantation. (Deshpande SR, Zangwill SD, Richmond ME, Kindel SJ, Schroder JN, Gaglianello N, Bichell DP, Wigger MA, Knecht KR, Thrush PT, Mahle WT, North PE, Simpson PM, Zhang L, Dasgupta M, Tomita-Mitchell A, Mitchell ME) Pediatr Transplant 2024 May;28(3):e14708 6 Citations |
| 1 | A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA. (Doebley AL, Ko M, Liao H, Cruikshank AE, Santos K, Kikawa C, Hiatt JB, Patton RD, De Sarkar N, Collier KA, Hoge ACH, Chen K, Zimmer A, Weber ZT, Adil M, Reichel JB, Polak P, Adalsteinsson VA, Nelson PS, MacPherson D, Parsons HA, Stover DG, Ha G) Nat Commun 2022 Dec 03;13(1):7475 69 Citations |
| 1 | Liquid biopsy: current technology and clinical applications. (Nikanjam M, Kato S, Kurzrock R) J Hematol Oncol 2022 Sep 12;15(1):131 571 Citations |
| 1 | Multi-omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown. (Kato S, Gumas S, Adashek JJ, Okamura R, Lee S, Sicklick JK, Kurzrock R) Mol Oncol 2024 Apr;18(4):956-968 9 Citations |
| 5 | Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. (Richmond ME, Deshpande SR, Zangwill SD, Bichell DP, Kindel SJ, Mahle WT, Schroder JN, Wigger MA, Knecht KR, Pahl E, Gaglianello NA, Goetsch MA, Simpson P, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME) J Thorac Cardiovasc Surg 2023 Feb;165(2):460-468.e2 9 Citations |
| 2 | Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation. (Deshpande SR, Zangwill SD, Kindel SJ, Schroder JN, Bichell DP, Wigger MA, Richmond ME, Knecht KR, Pahl E, Gaglianello NA, Mahle WT, Stamm KD, Simpson PM, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME) Pediatr Transplant 2022 Jun;26(4):e14264 11 Citations |
| 7 | Elevated nuclear and mitochondrial cell-free deoxyribonucleic acid measurements are associated with death after infant cardiac surgery. (Scott JP, Tanem JM, Tomita-Mitchell A, Hoffman GM, Niebler RA, Liang HL, Simpson PM, Stamm KD, North PE, Mitchell ME) J Thorac Cardiovasc Surg 2022 Aug;164(2):367-375 8 Citations |
| 1 | Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary. (Kato S, Weipert C, Gumas S, Okamura R, Lee S, Sicklick JK, Saam J, Kurzrock R) JCO Precis Oncol 2021;5 |
| 1 | Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. (Goodman AM, Holden KA, Jeong AR, Kim L, Fitzgerald KD, Almasri E, McLennan G, Eisenberg M, Jahromi AH, Hoh C, Hurley M, Mulroney C, Tzachanis D, Ball ED, Jensen TJ, Kurzrock R) Transplant Cell Ther 2022 Jan;28(1):30.e1-30.e7 20 Citations |
| 5 | Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. (Zangwill SD, Deshpande SR, Simpson PM, Liang HL, Zhang L, Dasgupta M, Richmond ME, Kindel SJ, Bichell DP, Mahle WT, Wigger MA, Schroder JN, Knecht KR, Pahl E, Gaglianello NA, North PE, Tomita-Mitchell A, Mitchell ME) Clin Transplant 2022 Jan;36(1):e14509 4 Citations |
| 1 | Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. (Jensen TJ, Goodman AM, Ellison CK, Holden KA, Kato S, Kim L, Daniels GA, Fitzgerald K, McCarthy E, Nakashe P, Mazloom AR, Almasri E, McLennan G, Grosu DS, Eisenberg M, Kurzrock R) Mol Cancer Ther 2021 Nov;20(11):2274-2279 8 Citations |
| 1 | Tumor DNA Mutations From Intraparenchymal Brain Metastases Are Detectable in CSF. (Cheok SK, Narayan A, Arnal-Estape A, Gettinger S, Goldberg SB, Kluger HM, Nguyen D, Patel A, Chiang V) JCO Precis Oncol 2021;5 17 Citations |
| 1 | High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. (Okamura R, Piccioni DE, Boichard A, Lee S, Jimenez RE, Sicklick JK, Kato S, Kurzrock R) Int J Cancer 2021 Jun 01;148(11):2839-2847 27 Citations |
| 1 | Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy. (Zhang Y, Pisano M, Li N, Tan G, Sun F, Cheng Y, Zhang Y, Cui X) Cell Signal 2021 Feb;78:109872 22 Citations |
| 5 | Total Cell-Free DNA Predicts Death and Infection Following Pediatric and Adult Heart Transplantation. (Scott JP, Ragalie WS, Stamm KD, Mahnke DK, Liang HL, Simpson PM, Dasgupta M, Katz R, North PE, Tomita-Mitchell A, Zangwill SD, Kindel SJ, Mitchell ME) Ann Thorac Surg 2021 Oct;112(4):1282-1289 13 Citations |
| 4 | Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. (Richmond ME, Zangwill SD, Kindel SJ, Deshpande SR, Schroder JN, Bichell DP, Knecht KR, Mahle WT, Wigger MA, Gaglianello NA, Pahl E, Simpson PM, Dasgupta M, North PE, Hidestrand M, Tomita-Mitchell A, Mitchell ME) J Heart Lung Transplant 2020 May;39(5):454-463 82 Citations |
| 5 | Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability. (North PE, Ziegler E, Mahnke DK, Stamm KD, Thomm A, Daft P, Goetsch M, Liang HL, Baker MA, Vepraskas A, Rosenau C, Dasgupta M, Simpson P, Mitchell ME, Tomita-Mitchell A) PLoS One 2020;15(1):e0227385 33 Citations |
| 1 | Dysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients. (Ebadi N, Ghafouri-Fard S, Taheri M, Arsang-Jang S, Parsa SA, Omrani MD) Eur J Pharmacol 2020 Jan 15;867:172852 16 Citations |
| 2 | Early changes in cell-free DNA levels in newly transplanted heart transplant patients. (Zangwill SD, Kindel SJ, Ragalie WS, North PE, Pollow A, Hidestrand M, Tomita-Mitchell A, Stamm KD, Mitchell ME) Pediatr Transplant 2020 Feb;24(1):e13622 21 Citations |
| 1 | Effect of endomyocardial biopsy on levels of donor-specific cell-free DNA. (Zangwill SD, Stamm KD, Hidestrand M, Tomita-Mitchell A, Mitchell ME) J Heart Lung Transplant 2019 Oct;38(10):1118-1120 8 Citations |
| 1 | Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. (Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S, Abdel-Wahab O, Durham BH, Meric-Bernstam F, Kurzrock R) Mol Cancer Ther 2019 Jun;18(6):1149-1157 29 Citations |
| 1 | Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. (Jensen TJ, Goodman AM, Kato S, Ellison CK, Daniels GA, Kim L, Nakashe P, McCarthy E, Mazloom AR, McLennan G, Grosu DS, Ehrich M, Kurzrock R) Mol Cancer Ther 2019 Feb;18(2):448-458 71 Citations |
| 3 | Noninvasive Assay for Donor Fraction of Cell-Free DNA in Pediatric Heart Transplant Recipients. (Ragalie WS, Stamm K, Mahnke D, Liang HL, Simpson P, Katz R, Tomita-Mitchell A, Kindel SJ, Zangwill S, Mitchell ME) J Am Coll Cardiol 2018 Jun 26;71(25):2982-2983 27 Citations |
| 1 | Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. (Du M, Thompson J, Fisher H, Zhang P, Huang CC, Wang L) Lung Cancer 2018 Jun;120:113-121 42 Citations |
| 1 | JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis. (Choi MY, Kato S, Wang HY, Lin JH, Lanman RB, Kurzrock R) Cancer Biol Ther 2018 Aug 03;19(8):664-668 3 Citations |
| 1 | BRAF mutation as a novel driver of eosinophilic cystitis. (Choi MY, Tsigelny IF, Boichard A, Skjevik ÅA, Shabaik A, Kurzrock R) Cancer Biol Ther 2017 Sep 02;18(9):655-659 5 Citations |
| 1 | Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology. (Husain H, Nykin D, Bui N, Quan D, Gomez G, Woodward B, Venkatapathy S, Duttagupta R, Fung E, Lippman SM, Kurzrock R) Mol Cancer Ther 2017 May;16(5):948-955 80 Citations |
